Circle Pharma announced publication of research in the Journal of Medicinal Chemistry highlighting optimization of oral cyclin A/B RxL inhibitors.
Srilata Bagchi (University of Illinois at Chicago): "The loss of retinoblastoma tumor suppressor gene function has been associated with the etiology of various types of tumors. The product of this ...